Baidu
map

Arthritis res ther :RA患者关节术后MI风险更高!

2016-03-31 MedSci MedSci原创

近期发表在Arth Res Ther的一项回顾性队列研究称,关节术后,伴类风湿性关节炎(RA)的患者,其心肌梗死(MI)风险更高!研究者对240,571名患者,共计308,589次关节手术进行了数据分析,其中有3,654患者伴有RA。通过相关数据库识别患者的人口统计学和医疗相关信息,以及关节术后随访2年的情况。此外研究者还根据关节手术部位,将患者进行亚组分析(全髋关节置换术组和全膝关节置换术组)。

近期发表在Arth Res Ther的一项回顾性队列研究称,关节术后,伴类风湿性关节炎(RA)的患者,其心肌梗死(MI)风险更高!

研究者对240,571名患者,共计308,589次关节手术进行了数据分析,其中有3,654患者伴有RA。通过相关数据库识别患者的人口统计学和医疗相关信息,以及关节术后随访2年的情况。

此外研究者还根据关节手术部位,将患者进行亚组分析(全髋关节置换术组和全膝关节置换术组)。使用查尔森合并症指数对混杂因素进行校正。

总的来说,RA患者年龄更大,女性患者伴有更多的合并症,经济社会地位更低,不过吸烟比例更少。

研究数据显示,在关节术后第6周,其中伴有RA的患者其MI的校正后风险aOR=1.5;关节术后1年,MI的aOR=1.7,全因死亡风险OR=2.18,心血管事件死亡风险OR=2.3。

除全髋关节置换术和全膝关节置换术,与不伴RA的关节术后患者相比,RA患者术后6周和1年的MI风险更高。

原始出处:

Tropea J, et al. Higher risk for MI after joint surgery seen among patients with RA,Arthritis Res Ther. 2016;doi:10.1186/s13075-016-0958-5.

Higher risk for MI after joint surgery seen among patients with RA.Healio.March 30, 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1972352, encodeId=ceb819e23525b, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sat Oct 22 06:02:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75345, encodeId=1ddfe5345bb, content=多学科治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Sun Apr 03 08:42:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356065, encodeId=d42d13560653b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 02 02:02:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74999, encodeId=d233e4999a8, content=新发现啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:41:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75000, encodeId=7bade5000c4, content=值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:41:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1972352, encodeId=ceb819e23525b, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sat Oct 22 06:02:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75345, encodeId=1ddfe5345bb, content=多学科治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Sun Apr 03 08:42:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356065, encodeId=d42d13560653b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 02 02:02:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74999, encodeId=d233e4999a8, content=新发现啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:41:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75000, encodeId=7bade5000c4, content=值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:41:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
    2016-04-03 1de00086m73(暂无匿称)

    多学科治疗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1972352, encodeId=ceb819e23525b, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sat Oct 22 06:02:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75345, encodeId=1ddfe5345bb, content=多学科治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Sun Apr 03 08:42:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356065, encodeId=d42d13560653b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 02 02:02:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74999, encodeId=d233e4999a8, content=新发现啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:41:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75000, encodeId=7bade5000c4, content=值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:41:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
    2016-04-02 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1972352, encodeId=ceb819e23525b, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sat Oct 22 06:02:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75345, encodeId=1ddfe5345bb, content=多学科治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Sun Apr 03 08:42:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356065, encodeId=d42d13560653b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 02 02:02:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74999, encodeId=d233e4999a8, content=新发现啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:41:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75000, encodeId=7bade5000c4, content=值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:41:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
    2016-03-31 milkshark

    新发现啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1972352, encodeId=ceb819e23525b, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sat Oct 22 06:02:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75345, encodeId=1ddfe5345bb, content=多学科治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Sun Apr 03 08:42:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356065, encodeId=d42d13560653b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 02 02:02:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74999, encodeId=d233e4999a8, content=新发现啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:41:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75000, encodeId=7bade5000c4, content=值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:41:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
    2016-03-31 milkshark

    值得推荐

    0

相关资讯

AIM:手术患者接种疫苗预防流感有潜在危险吗?

尽管已经建议住院手术患者接种疫苗预防流感,但疫苗接种率在这一人群中仍然很低,部分原因是对于有关手术后护理的潜在负面影响的担忧。该研究的目的是评估在围手术期接种流感疫苗是否增加卫生服务利用和评价的出院后手术后感染。该前瞻性队列研究在南加州Kaiser Permanente进行,研究的患者年龄为6个月或以上,入院进行手术,在20109月1日至2013年3月31日进行。所有流感疫苗接种在2010-201

Diabetologia:肥胖2型糖尿病患者,手术 vs.饮食运动+药物

越来越多的证据表明,Roux-en-Y胃旁路手术(RYGB)能改善2型糖尿病。研究者进行了一项随机对照试验,比较RYGB和强化的生活方式与药物干预(ILMI)对2型糖尿病患者的影响(包括BMI<35 kg/m2的患者)。共有1808名成年人2型糖尿病患者符合纳入标准(年龄25-64岁,BMI在30-45kg/m2之间),其中有43人通过盲法按1:1分为RYGB或ILMI组。LIMI组的患者进

Gastroenterology:克罗恩女性患者应谨慎使用避孕药

背景:口服避孕药(OCs)含有外源性激素,而外源性激素与克罗恩病(CD)风险有关联。然而,OCs能否促进CD的发展,目前尚不清楚。方法:纳入2002年1月-2013年12月间瑞典国家病人数据库的16-51岁女性CD患者,通过处方数据库获取患者2005年7月时OC使用情况,在2013年12月更新患者OC的使用情况。第一次CD相关的手术和第一次使用类固醇治疗的处方作为主要终点。使用含随时间变化的协变量

彻底改变人类健康的5份研究报告

在医院的候诊大厅里,你不可能找到类似于《柳叶刀》、《美国医学会杂志》这样的期刊,但是这些杂志对你的健康却产生了实实在在的影响。 在这些杂志里,科学家们发表研究结果,综述文献,向世人介绍:疾病是如何发生的?哪些药物可以拯救生命?哪种手术方法是最好的? 第一个科学杂志《哲学汇刊》(Philosophical Transactions)  发行于350年前。现在仍在刊印,拥有数

Infect Control Hosp Ep:糖尿病是手术部位感染的独立危险因子

研究者检索了Pubmed数据库中关于糖尿病和手术部位感染(SSI)相关的文献,进行系统回顾和荟萃分析。经过筛查后,共纳入了94篇文章进行分析。研究者手收集了糖尿病、血糖、BMI等相关资料,合并后使用随机效应模型进行荟萃分析,使用meta回归分析评估异质性。研究以SSI(疾病预防控制中心的标准定义)为主要结局指标。分析结果显示,总体来看,糖尿病对SSI的OR=1.53 (95% PI, 1.11-2

Spine:等待孩子手术的过程中,术中短信能降低父母的焦虑

一项前瞻性、非随机试验结果表明,当孩子进行后路脊柱融合术(PSF)时,父母接受到外科医生术中发出的短信,可减少焦虑(与没有收到术中短信的父母相比)。该研究纳入了2个中心的青少年特发性脊柱侧凸(AIS)患者的96名父母(47名父亲和49名母亲),其中1个中心的父母在术中没有收到任何短信(组1),另一组的父母则在术后能收到外科医生的短信(组2)。分别在PSF术前(P1)、术中分离(P2)、手术1小时(

Baidu
map
Baidu
map
Baidu
map